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Abstract. Polymorphisms in the inducible nitric oxide synthase gene (NOS2) prom oter have been associated with 
clinical outcome from malaria. These include a CCTTT repeat (CCTTTn) 2.5 kilobases upstream  from the NOS2 
transcription start site, and two single nucleotide substitutions: G ^-C  at position -954 (G-954C), and C ^-T  at position 
-1173 (C-1173T). Although hypothesized to influence NO production in vivo, the functional relevance of (CCTTT)n and 
G-954C is uncertain because disease association studies have yielded inconsistent results. This study found no association 
between CCTTT repeat num ber and levels of plasma NO m etabolites or peripheral blood m ononuclear cell NOS activity 
in a cohort of asymptomatic malaria-exposed coastal Papua New Guineans 1-60 years old. This suggests that (CCTTT)n 
does not independently influence NOS2 transcription in vivo. Neither the G-954C nor the C-1173T polymorphisms were 
identified in this population, indicating the variability and complexity of selection for NOS2 prom oter polymorphisms 
in different malaria-endemic populations.
INTROD U CTIO N
Our group and others have dem onstrated an inverse asso­
ciation between nitric oxide (NO ) production/peripheral 
blood m ononuclear cell (PBMC) nitric oxide synthase (NOS) 
expression and malarial disease severity.1^ 3 In contrast to the 
absent or minimal PBMC inducible nitric oxide synthase gene 
(NOS2) expression in healthy residents of tem perate cli­
mates.43 basal PBMC NOS expression and activity is high in 
apparently healthy asymptomatic residents of tropical m a­
laria-endem ic reg ions.1,2 Factors po tentially  influencing 
NOS2 transcription in these populations include age, pres­
ence of subclinical coinfections, parasite polymorphisms, and 
host polymorphisms in NOS2 and other regulatory cytokine 
genes. Four polymorphisms in the NOS2 prom oter have been 
associated with malarial disease outcome: a CCTTT micro­
satellite repeat (CCTTTn) located 2.5 kilobases upstream  
from the NOS2 transcription start site;6 and single nucleotide 
substitutions from G ^-C  at position -954 (G-954C),7 from 
C^-T at position -1173 (C-1173T),8 and A ^-T  at position 
-1659 (A-1659T).9
Conflicting results have been obtained from studies of the 
(CCTTT)n polymorphism both in vivo and in vitro. Shorter 
forms of the CCTTT repeat (both alleles 10 repeats) and a 
reduced summed repeat length were associated with fatal ce­
rebral m alaria in Gambian children,6 whereas longer forms 
(either allele ^  15 repeats) and increased summed repeat 
length were associated with severe m alaria in Thai adults.10 In 
contrast, CCTTT repeat length was not associated with m a­
larial disease severity or NO production in Tanzanian11 or 
Gabonese children,12 nor malarial disease severity in Kenyan 
children.8 Interleukin-1 (3- induced NOS2 transcription in 
transfected colonic carcinoma cells was reported to be most 
effective in constructs with ( C C T T T ) , ; A nother in vitro 
study reported no differences in basal or cytokine-induced 
NOS2 prom oter activity by constructs with deletions in the 
CCTTT repeat region.14 Reports on the functional relevance
of the G-954C polymorphism have also led to different con­
clusions. This polymorphism was over-represented in G a­
bonese children with mild malaria compared with those with 
severe malaria,7 and was associated with an increased time to 
symptomatic reinfection.12 However, the G-954C mutation 
was not associated with risk of cerebral malaria in Tanzanian 
or Gambian children.9,11
Since geographic variation in susceptibility to malaria and 
disease phenotype may be due to differences in host genetics, 
parasite strains, and malaria epidemiology, the functional sig­
nificance of these conflicting observations is unclear. We 
therefore assessed the relationship of the (CCTTT)n, G-954C, 
and C-1173T polymorphisms to in vivo NO production in a 
highly malaria-exposed coastal Papua New G uinean popula­
tion. This population was expected to exhibit the high basal 
NO production and PBMC NOS activity that is characteristic 
of residents in tropical environments. This high production/ 
activity is thought to reflect chronic stimulation of NOS2 by 
malaria and other subclinical infections,1,2 and has been pre­
viously used to dem onstrate higher NO production in those 
with disease-protective NOS2 polymorphisms.8 W e carefully 
selected strictly-defined asymptomatic subjects, so that basal 
NO production/NOS activity would not be confounded by the 
disease responses typically associated  w ith tem porarily  
skewed production of pro and/or anti-inflammatory cytokines 
that may regulate NOS2 transcription. W e also tested a priori 
hypotheses generated from the results of the aforementioned 
studies in relation to basal NO production.6,10,13
M ATERIALS AND M ETHODS
Informed consent was obtained from all human adult par­
ticipants, and from parents or legal guardians of minors, after 
ethical approval to conduct the study was obtained from the 
H ealth Research Ethics Committee of the Menzies School of 
H ealth  Research, N orthern  Territory, A ustralia, and the 
Papua New Guinea Medical Research Advisory Committee.
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Asym ptom atic intensely m alaria-exposed children and 
adults were recruited from two coastal villages located ap­
proximately 20 km north of Madang, Papua New Guinea as 
previously described (n =  216, median age =  13 years, age 
range =  1-60 years, 45% male, and 70% parasitemic).15 Vol­
unteers were excluded from enrollment if they were febrile on 
any of three occasions over a 24-hour period (axillary tem ­
perature >  37.5°C); had taken anti-malarial or non-steroidal 
anti-inflammatory medication within the past week; had clini­
cal evidence of malaria infection within the past week (fever, 
chills, sweats, headache, or myalgia); had a history of infec­
tion (other than the common cold) in the past week; or had 
diarrhea. The Madang region is characterized by infection 
with all four human malaria species and there is little seasonal 
variation in parasitemia rates.16 Residents are estimated to 
receive on average close to one infective bite per day,17 with 
an increase in transmission during the wet season from Oc­
tober to May.18 Parasite prevalence reaches its peak of more 
than 60% in the 5-9-year-old age group, which is later than 
that commonly observed from hyperendemic regions in Af­
rica.16’19 Small area variations in endemicity have been re­
ported within a 22-km radius of Madang, with the study vil­
lages located within the high epidemiologic zone.17 Clinical 
malaria epidemiology in the M adang region has been well 
described in children 2-15 years old and is characterized by a 
low incidence of severe disease, with episodic mild malaria 
that decreases in frequency from approximately five fever 
episodes per year at age 2 to  one per year at age 14.19
Baseline plasma NO metabolites (NOx) were m easured in 
186 subjects after a 12-hour fast that followed a low nitrate 
meal, using Aspergillus nitrate reductase coupled with the 
Griess reaction.20 The NOS activity was determ ined in PBMC 
pellet lysates from 173 subjects by measuring the m olar 
am ount of 14C-arginine that was converted to  citrulline per 
milligram of total cellular protein/hour.4 Baseline samples 
from the remaining subjects were either not available or re­
jected if the subject was symptomatic and met the exclusion 
criteria, or if treatm ent that could potentially influence NO 
production had been recently administered. Parasitemia sta­
tus was determ ined by microscopy of thick blood films on two 
occasions over a 24-hour period as previously described.15
W hole blood was spotted onto filter paper in the field, from 
which 3-mm disks were later punched in the laboratory and 
then purified using a D N A  purification solution according to 
m anufacturer’s instructions (G entra, Minneapolis, MN). The 
whole genome was amplified in 50-jaL reactions containing 1 
mM dNTPs, 6 ng of random decamers (Gigaprime Kit; Gene- 
works, Adelaide, Australia); and five units of H otS tar Taq 
polymerase (Qiagen, Clifton Hill, Victoria, Australia) in a 
reaction buffer containing 67 mM Tris-HCl, 2.5 mM MgCl,, 
16 mM (NH4)2S 0 4, and 0.01% Tween 20. Samples were ini­
tially held at 92°C for 15 minutes to activate the H otStar Taq 
and then cycled 50 times at 92°C for one minute, 37°C for two 
minutes, and 55°C for four minutes (after a 10-second ramp to 
55°C). The D N A  product from the first-round polymerase 
chain reaction (PCR) was subsequently used as the template 
in each of the second round  PC R s for genotyping the 
(CCTTT),,.11 G-954C,11 and C-1173T polymorphisms,8 and 
was successful in 204, 215, and 212 subjects, respectively.
Plasma NOx and NOS activity data were normalized by log 
transform ation and analyzed according to the a priori and 
post-hoc analyses by Student’s f-tests appropriate for vari­
ance. The relationship between plasma NOx'NOS activity 
and summed CCTTT repeat length was analyzed using linear 
regression. All statistical analyses were perform ed using Stata
7.0 statistical software (Stata Corp., College Station, TX) and 
P values < 0.05 were considered to indicate statistical signifi­
cance.
RESULTS
All individuals were homozygous for the wild-type G-954 
and C-1173 alleles, with the G-954C and C-1173T polymor­
phisms being absent from the D N A  of all subjects genotyped. 
The (CCTTT)n alleles were bimodally distributed with peaks 
at 11 and 13 (Figure la ), and the summed num ber of both 
allelic CCTTT repeats was normally distributed around a 
m ean of 24 (SD =  2.8; Figure lb ). The geometric means for 
plasma NOx and PBM C NOS activity were 37 |xmol/L (95% 
confidence interval [CI] =  34-40) and 1,020 pmol/mg (95% 
CI =  920-1,130), respectively. As expected, these values in 
asymptomatic residents of a tropical environment were m ark­
edly elevated relative to that we have previously found in 
fasting healthy subjects from the U nited States (Figure 2).s
Since only two subjects w ere homozygous for ‘‘sho rt” 
(CCTTT)n alleles <  10 repeats 6 we could not statistically 
compare NO production in these subjects with others. The 
summed number of CCTTT repeats6,10 was not significantly 
related to  plasma NOx (R2 =  0.005, P =  0.38) (Figure 2a) or 
PBM C NOS activity (R2 =  0.002, P =  0.56) (Figure 2b). 
Neither measure of NO production was different in those 
with the (C C T T T ),, allele13 (n =  23; P > 0.5 for both com­
parisons) or in subjects with at least one allele of s  15 re­
peats10 (n =  46; P > 0.8 for both comparisons). In a post-hoc 
analysis, there was no difference in NO production in subjects 
in whom both alleles were <  11 CCTTT repeats (i.e., equiva­
lent to  the lower bimodal peak defining shorter alleles in this 
population, n =  35; P > 0.25 for both comparisons). The 
potential covariates age, sex, and asymptomatic parasitemia 
(as previously defined15) were examined in multivariate lin­
ear regression models but did not significantly influence the 
results.
DISCUSSION
We have shown that two single nucleotide NOS2 prom oter 
polymorphisms previously linked with malarial disease sever­
ity in Africa (the G-954C12 and C-1173T8) are not present in 
Papua New G uinean subjects exposed to  intense malaria 
transmission. Furtherm ore, we have dem onstrated that the 
distribution of CCTTT repeat lengths differs from what has 
been reported previously in Africa and Thailand,6’10’11 with 
an increased frequency in the Papua New Guinean popula­
tion of (C C T T T ),, and (CCTTT)13 alleles. M ost importantly, 
we found no association between the number of CCTTT re­
peats and basal NO production in a large population whose 
basal plasma NOx and NOS activity was in excess of that we 
have found previously in non-malaria-exposed controls.5 A l­
though our measures of plasma NOx and NOS activity po­
tentially incorporate constitutive NO production by other 
NOS isoforms, NO production from these other sources is 
likely to  be minimal in the context of the high basal PBMC 
NOS2 expression dem onstrated in asymptomatic adults and
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independently influence NOS2 transcription. This is further 
supported by the following observations: results of clinical 
studies are conflicting, with severe malaria associated with 
“short” CCTTT repeats,6 long CCTTT repeats,10 or not at all 
independently associated with (CCTTT)n;11,12 basal and cy-
F i g u r e  1. a, Distribution of CCTTT repeat allele lengths in the 
nitric oxide synthase gene and b, summed allele lengths of both alleles 
in 204 children and adults from Madang, Papua New Guinea.
children resident in tropical environments.1,2,21 Given the 
contradictory nature of previous studies and the absence of 
functional effects in our study, it is im portant to reconcile our 
findings with those of previous reports.
If (CCTTT)n microsatellite repeat length independently in­
fluences NOS2 transcription, then we would have expected to 
have observed differences in chronically stimulated basal NO 
production in vivo. We have previously used such measures to 
dem onstrate higher in vivo NO production in African chil­
dren with a disease-protective NOS2 polymorphism.8 B e­
cause there was no relationship between repeat length and 
NO production in our study, we believe our data support the 
alternative hypothesis that CCTTT repeat length does not
F i g u r e  2. Relationship between in vivo nitric oxide (NO) pro­
duction and summed CCTTT repeat length in the nitric oxide syn­
thase (NOS) gene (i.e., of both alleles). Diamonds represent a, the 
fasting plasma NOx (n = 186) and b, NOS activity (n = 173) of 
malaria-exposed Papua New Guinean children and adults (age range 
= 1-60 years). The results of linear regression analyses of the data 
from Papua New Guinea are represented by solid lines. Open tri­
angles represent comparative data from 20 healthy adult controls 
from the United States (age range = 31-66 years) in whom plasma 
NOx was measured after 24 hours on a low nitrate diet. The baseline 
characteristics of these 20 controls have been previously described.5 
The geometric mean plasma NOx and NOS activity were significantly 
higher in Papua New Guinean subjects than in controls from the 
United States (P < 0.001 for both comparisons).
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tokine-induced in vitro NOS2 prom oter activity was unaf­
fected in luciferase constructs with deletions in the CCTTT 
repeat region;’4 and the num ber of post-hoc analyses in ge­
netic association studies may be under-appreciated and the 
significance of positive associations may not withstand statis­
tical correction for multiple comparisons.
The G-954C C-allele frequencies in malaria-endemic sub- 
S aharan  A frican  popu la tions have varied  from  7% to 
15% ” •’2 com pared with only 1-4%  in low-endemicity Thais’0 
and in an unidentified Papua New Guinean population that 
included subjects with m alaria,’0'’2 and an absence from G er­
mans7 and whites in the U nited States.”  The C-1.173T poly­
morphism was present with an allele frequency of 4% in T an­
zanian adults and western Kenyan children, but was absent 
from whites from the United States.8 Selective pressure for 
these polymorphisms may be altered by variation and fluc­
tuation in malarial transmission intensity on a geographic and 
temporal basis, as well as by exposure to  multiple other dis­
eases. The presence and prevalence of genetic polymorphisms 
may also vary among populations depending on factors other 
than selective pressure, including founder effect, migration, 
population sub-sampling, and various sociocultural factors 
that influence purely random mating. Thus, it is not surprising 
that there are major differences among populations in the 
genes controlling immunity to  malaria, especially given the 
potential for polymorphisms in other genes influencing anti- 
malarial immune responses and the necessity for balance in 
adaptation to other diseases.
The G-954C polymorphism was associated with higher 
basal NOS activity in cultured PBMCs, but did not appear to 
be associated with significantly increased NOS activity in 
freshly collected PBMCs ex vivo, in which NOS activity was 
10-fold higher than in the cultured cells.’2 Although associ­
ated with protection against severe anemia and hyperpara­
sitemia in Gabon,7 no association was found between the 
presence of the G-954C C-allele and either risk of cerebral 
malaria or NO production in Tanzanian children”  or with 
risk of cerebral malaria in Gam bian children.9 The C-1.173T 
polymorphism was associated with increased basal in vivo NO 
production and a substantially reduced risk of clinical malaria 
in Tanzanian children, and of severe malarial anemia in Ken­
yan children.8 The absence of the G-954C and C-1.173T poly­
morphisms from our Papua New Guinean population em pha­
sizes that selection of particular NOS2 polymorphisms pro­
tective in African populations is not universal among highly 
malaria-exposed populations, and precluded assessment of 
functionality in this setting.
How then should the present results be interpreted? First, 
our results highlight the importance of subjecting hypotheses 
derived from post-hoc analyses to  prospective analysis in fol­
low-up functional correlation studies. Second, our data em­
phasize that correlation studies should be directed at uncov­
ering whether the proposed polymorphisms (or linked “criti­
cal” polym orphism s) are present in regions tha t directly 
influence activation or repression of transcription. Third, we 
have identified geographic differences in the prevalence of 
potentially im portant immunoregulatory polymorphisms in 
populations of similarly intense malaria transmission, suggest­
ing that other undefined NOS2 prom oter polymorphisms may 
be functionally im portant in the Papua New G uinean popu­
lation. Alternatively, it is possible that immune responses re­
lated to  disease severity in one geographic region may be less
im portant in others where host genetics, parasites, and m a­
laria epidemiology may differ.
In conclusion, we have dem onstrated that the (CCTTT)n 
microsatellite repeat is not related to chronically stimulated 
basal NO production in highly malaria-exposed coastal Papua 
New G uinean subjects. If the genetically determ ined capacity 
to  produce NO is critical to  anti-malarial immunity, then our 
results and those of previous studies linking (CCTTT)n with 
divergent disease outcomes in post-hoc analyses6-’0 at the 
very least question the universal relevance of this polymor­
phism. The absence in a highly malaria-exposed Papua New 
Guinean population of two other single nucleotide polymor­
phisms associated with malarial disease severity in African 
populations indicates the variability and complexity of selec­
tion for NOS2 prom oter polymorphisms in malaria-endemic 
populations.
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